Isabelle Mahé

6.3k total citations
171 papers, 2.4k citations indexed

About

Isabelle Mahé is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Isabelle Mahé has authored 171 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Internal Medicine, 100 papers in Cardiology and Cardiovascular Medicine and 27 papers in Surgery. Recurrent topics in Isabelle Mahé's work include Venous Thromboembolism Diagnosis and Management (112 papers), Atrial Fibrillation Management and Outcomes (76 papers) and Central Venous Catheters and Hemodialysis (25 papers). Isabelle Mahé is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (112 papers), Atrial Fibrillation Management and Outcomes (76 papers) and Central Venous Catheters and Hemodialysis (25 papers). Isabelle Mahé collaborates with scholars based in France, Spain and United Kingdom. Isabelle Mahé's co-authors include Jean‐François Bergmann, Stéphane Mouly, Ludovic Drouet, Carmelo Lafuente‐Lafuente, Guy G. Simoneau, C Caulin, Virginie Siguret, Éric Pautas, H. L. Helfer and Jean Chidiac and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Isabelle Mahé

147 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Mahé France 27 1.5k 1.3k 385 326 224 171 2.4k
Minggao Shi United States 24 2.7k 1.8× 2.0k 1.5× 341 0.9× 306 0.9× 256 1.1× 44 3.3k
Geoffrey D. Barnes United States 26 1.9k 1.3× 1.9k 1.4× 418 1.1× 259 0.8× 550 2.5× 234 3.4k
Sarah A. Spinler United States 28 1.8k 1.2× 805 0.6× 846 2.2× 121 0.4× 269 1.2× 126 3.2k
Alejandro Lazo‐Langner Canada 29 1.0k 0.7× 1.6k 1.2× 588 1.5× 372 1.1× 291 1.3× 169 3.2k
Paul P. Dobesh United States 23 1.3k 0.9× 981 0.7× 432 1.1× 131 0.4× 227 1.0× 95 2.2k
Melissa Forgie Canada 11 939 0.6× 1.9k 1.4× 752 2.0× 357 1.1× 301 1.3× 16 2.8k
Alexander G.G. Turpie Canada 18 2.7k 1.8× 2.8k 2.1× 889 2.3× 483 1.5× 301 1.3× 48 3.7k
Emilio Vargas Spain 24 862 0.6× 701 0.5× 376 1.0× 90 0.3× 155 0.7× 102 2.5k
Henry G. Watson United Kingdom 19 1.1k 0.7× 1.2k 0.9× 559 1.5× 119 0.4× 400 1.8× 37 3.0k
Lori‐Ann Linkins Canada 27 1.4k 0.9× 2.2k 1.7× 1.4k 3.6× 298 0.9× 184 0.8× 64 3.0k

Countries citing papers authored by Isabelle Mahé

Since Specialization
Citations

This map shows the geographic impact of Isabelle Mahé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Mahé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Mahé more than expected).

Fields of papers citing papers by Isabelle Mahé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Mahé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Mahé. The network helps show where Isabelle Mahé may publish in the future.

Co-authorship network of co-authors of Isabelle Mahé

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Mahé. A scholar is included among the top collaborators of Isabelle Mahé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Mahé. Isabelle Mahé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akbari, Ashley, Adrian Edwards, Kate Lifford, et al.. (2025). Anti‐thrombotic therapy in patients with cancer at the end of life: A cohort study using population‐linked routinely collected data. British Journal of Haematology. 207(5). 2080–2090.
2.
Blacher, Jacques, Philippe Tuppin, Grégory Lailler, et al.. (2024). Epidemiology of venous thromboembolism in France. Archives of cardiovascular diseases. 117(12). 715–724.
3.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2024). Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer ». La Revue de Médecine Interne. 45(4). 210–225. 2 indexed citations
4.
Couturaud, Françis, Olivier Sanchez, Nicolas Méneveau, et al.. (2024). Extended Treatment of Venous Thromboembolism with Reduced- Vs Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence. Blood. 144(Supplement 2). LBA–3. 1 indexed citations
5.
Carrier, Marc, et al.. (2024). Preventative and curative treatment of venous thromboembolic disease in cancer patients. La Presse Médicale. 53(4). 104242–104242.
6.
7.
Edwards, Adrian, Kathy Seddon, Anne Gulbech Ording, et al.. (2024). Involving patients and the public in cancer associated thrombosis research: A strategy for success. ORCA Online Research @Cardiff. 18. 100196–100196. 1 indexed citations
8.
Pernod, Gilles, Ariel Cohen, Patrick Mismetti, Olivier Sanchez, & Isabelle Mahé. (2023). Cancer-related arterial thromboembolic events. Archives of cardiovascular diseases. 117(1). 101–113. 5 indexed citations
9.
Élias, Antoine, P. Debourdeau, Olivier Espitia, et al.. (2023). Central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Diagnosis and therapeutic management. Archives of cardiovascular diseases. 117(1). 72–83. 7 indexed citations
10.
Debourdeau, P., Marie‐Antoinette Sevestre, Laurent Bertoletti, et al.. (2023). Treatment of cancer-associated venous thromboembolism in patients under palliative care. Archives of cardiovascular diseases. 117(1). 94–100.
11.
12.
Sevestre, Marie‐Antoinette, et al.. (2023). Care pathways for patients with cancer-associated thrombosis: From diagnosis to long-term follow-up. Archives of cardiovascular diseases. 117(1). 6–15. 4 indexed citations
13.
14.
Poénou, Géraldine, et al.. (2022). In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients. Cancers. 14(8). 1937–1937. 12 indexed citations
15.
Maraveyas, Anthony, Noémie Kraaijpoel, George Bozas, et al.. (2021). The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study. Journal of Thrombosis and Haemostasis. 19(11). 2791–2800. 7 indexed citations
16.
Barco, Stefano, Frederikus A. Klok, Isabelle Mahé, et al.. (2018). Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. Thrombosis Research. 173. 166–171. 40 indexed citations
17.
Mahé, Isabelle, et al.. (2018). Protected adults’ voting rights: an interdisciplinary study of medical assessment and jurisprudence in France. BMJ Open. 8(7). e020522–e020522. 1 indexed citations
18.
Meune, Christophe, Karim Wahbi, Yvonne Fulla, et al.. (2006). Effects of Aspirin and Clopidogrel on Plasma Brain Natriuretic Peptide in Patients with Heart Failure Receiving ACE Inhibitors. European Journal of Heart Failure. 9(2). 197–201. 12 indexed citations
19.
Mahé, Isabelle, Stéphane Mouly, K. Champion, & Jean‐François Bergmann. (2005). Méga-essais : définitions, caractéristiques, interrogations et exigences réglementaires. 11(4). 269–274.
20.
Mahé, Isabelle. (2004). Principes d’utilisation du traitement anticoagulant chez le sujet âgé en médecine. Sang thrombose vaisseaux. 16(7). 339–345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minggao Shi Breakdown of academic impact, for papers by Geoffrey D. Barnes Breakdown of academic impact, for papers by Sarah A. Spinler Breakdown of academic impact, for papers by Alejandro Lazo‐Langner Breakdown of academic impact, for papers by Paul P. Dobesh Breakdown of academic impact, for papers by Melissa Forgie Breakdown of academic impact, for papers by Alexander G.G. Turpie Breakdown of academic impact, for papers by Emilio Vargas Breakdown of academic impact, for papers by Henry G. Watson Breakdown of academic impact, for papers by Lori‐Ann Linkins
Rankless by CCL
2026